HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Jähnichen Selected Research

Lisuride

3/2006Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Jähnichen Research Topics

Disease

2Migraine Disorders (Migraine)
03/2006 - 07/2004
1Parkinson Disease (Parkinson's Disease)
04/2006
1Pericarditis
03/2006
1Pleural Effusion (Pleural Effusions)
03/2006
1Pleurisy (Pleuritis)
03/2006
1Drug-Related Side Effects and Adverse Reactions
03/2006
1Fibrosis (Cirrhosis)
03/2006

Drug/Important Bio-Agent (IBA)

2Dopamine Agonists (Dopamine Agonist)IBA
04/2006 - 03/2006
1protergurideIBA
04/2006
1Pergolide (Permax)FDA Link
03/2006
1ProlactinIBA
03/2006
15-HT2B Serotonin ReceptorIBA
03/2006
1CabergolineFDA LinkGeneric
03/2006
1Bromocriptine (Parlodel)FDA LinkGeneric
03/2006
1Dopamine (Intropin)FDA LinkGeneric
03/2006
1LisurideIBA
03/2006
1Tryptamines (Triptans)IBA
07/2004

Therapy/Procedure

1Cutaneous Administration
04/2006
1Therapeutics
04/2006